12/10
07:49 am
mygn
Rating for MYGN
Low
Report
Rating for MYGN
12/10
07:01 am
mygn
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $18.00 price target on the stock.
Medium
Report
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $18.00 price target on the stock.
12/10
05:24 am
mygn
Myriad Genetics initiated with a Neutral at UBS
Medium
Report
Myriad Genetics initiated with a Neutral at UBS
12/9
08:04 am
mygn
Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $21.00 price target on the stock, down previously from $30.00.
Medium
Report
Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $21.00 price target on the stock, down previously from $30.00.
12/9
07:31 am
mygn
Rating for MYGN
Low
Report
Rating for MYGN
12/9
06:13 am
mygn
Myriad Genetics downgraded to Market Perform from Outperform at Leerink
Medium
Report
Myriad Genetics downgraded to Market Perform from Outperform at Leerink
11/18
08:24 am
mygn
Rating for MYGN
Medium
Report
Rating for MYGN
11/18
08:24 am
mygn
Rating for MYGN
Medium
Report
Rating for MYGN